T and natural killer cell lymphoma. Histological and immunohistochemical aspects;Lymphomes T et 'natural killer'. Aspects histopathologiques, immunologiques et moleculaires

Annales de Pathologie

Volumn 18, Issue 4, 1998, Pages 299-314

  Kanavaros, P ^a,b   Gaulard, P ^a  

^a HENRI MONDOR HOSPITAL   (France)

^b UNIVERSITY OF CRETE   (Greece)

Author keywords

Cytotoxic; EBV; NK lymphoma; T lymphoma

Indexed keywords

CANCER DIAGNOSIS; EPSTEIN BARR VIRUS; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPHOMA; NATURAL KILLER CELL; REVIEW; T CELL LYMPHOMA;

GENOME, HUMAN; HERPESVIRUS 4, HUMAN; HUMANS; IMMUNOHISTOCHEMISTRY; KARYOTYPING; KILLER CELLS, NATURAL; LYMPHOMA, LYMPHOBLASTIC; LYMPHOMA, T-CELL; LYMPHOMA, T-CELL, PERIPHERAL;

EID: 0031690995     PISSN: 02426498     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (102)

1. STANSFELD A, DIEBOLD J, KAPANCI Y, KELENYI G, LENNERT K, MIODUSZEWSKA O et al. Updated Kiel classification for lymphomas. Lancet 1988 ; i : 292-3.
2. HARRIS NL, JAFFE ES, STEIN H, BANKS PM, CHAN JKC, CLEARY ML et al. A revised European-American Classification of lymphoid neoplasms: a proposal from the international lymphoma study group. Blood 1994 ; 84 : 1361-92.
3. LENNERT K, FELLER AC. Histopathology of non-Hodgkin's lymphomas. Springer-Verlag. Berlin, 2nd ed., 1992.
4. e éd, éds Frison-Roche, Paris, 1997.
5. Non-Hodgkin's lymphoma pathologic classification project. National Cancer Institute sponsored study of classifications of non-Hodgkin's lymphomas: Summary and description of a Working Formulation for clinical usage. Cancer 1982 ; 49 : 2112-35.
6. GISSELBRECHT C, GAULARD P, LEPAGE E, COIFFIER B, BRIÈRE J, HAIOUN C et al. Prognostic significance of T-cell phenotype in aggressive non-Hodgkin's lymphomas. Blood 1998 ; 92 : 76-82.
7. CHOTT A, AUGUSTIN I, WRBA FR, HANAK H, OHLIGER W, RADASZKIEWICZ T. Peripheral T-cell lymphomas: a clinicopathologic study of 75 cases Hum Pathol 1990 ; 21 : 1117-25.
8. HASTRUP N, HAMILTON-DUTOIT S, RALFKIAER E, PALLESEN G. Peripheral T-cell lymphomas: an evaluation of reproducibility of the updated Kiel classification. Histopathology 1991 ; 18 : 99-105.
9. PICKER LJ, MICHIE SA, ROTT LS, BUTCHER EC. A unique phenotype of skin-associated lymphocytes in humans. Preferential expression of the HECA-452 epitope by benign and malignant T-cells at cutaneous sites. Am J Pathol 1990 ; 136 : 1053-68.
10. PALS ST, MEIJER CJLM, RADASZKIEWICZ T. Expression of the human peripheral lymph node homing receptor (LECAM-1) in nodal and gastrointestinal non-Hodgkin's lymphomas. Leukemia 1991; 5 : 628-31.
11. KANAVAROS P, DE BRUIN PC, BRIÈRE J, MEIJER C, GAULARD P. EBV in extranodal T-NHL. Identification of nasal T-NHL as a distinct clinicopathological entity associated with EBV. Leuk Lymphoma 1994 ; 18 : 27-34.
12. DE BRUIN PC, JIWA NM, OUDEJANS JJ, VAN HEERDE P, SABOURIN JC, CSANAKY G et al. Presence of Epstein Barr virus in extranodal T-cell lymphomas: differences in relation to site. Blood 1994 ; 83 : 1612-8.
13. DE BRUIN PC, KUMMER JA, VAN DER WALK P, VAN HEERDE P, KLUIN PM, WILLEMZE R et al. Granzyme B expressing peripheral T-cell lymphomas: Neoplastic equivalents of activated cytotoxic T-cells with preference for mucosa associated lymphoid tissue (malt) localization. Blood 1994 ; 84 : 3785-91.
14. DE BRUIN PC, BELJAARDS RC, VAN HEERDE P, VAN DER VALK P, NOORDUYN LA, VAN KRIEKEN JHJM et al. Differences in clinical behaviour and immunophenotype between primary cutaneous and primary nodal large cell anaplastic lymphoma of T-cell or null cell phenotype. Histopathology 1993 ; 23 : 127-34.
15. JAFFE ES. Pathologic and clinical spectrum of post-thymic T-cell malignancies. Cancer Invest 1984 ; 2 : 413-35
16. JAFFE ES, CHAN JKC, SU IJ, FRIZZERA G, MORI S, FELLER AC et al. Report of the workshop on nasal and related extranodal angiocentric T/Natural killer cell lymphomas. Definitions, differential diagnosis and epidemiology. Am J Surg Pathol 1996 ; 20 : 103-12.
17. KNOWLES DM, CHADBURN A, INGHIRAMI G. Immunophenotypic markers useful in the diagnosis and classification of hematopoietic neoplasms. In: KNOWLES DM eds. Neoplastic Hematopathology, Williams and Wilkins, Baltimore, USA, 1992. pp 73-167.
18. PICKER LJ, WEISS LM, MEDEIROS LJ, WOOD GS, WARNKE RA. Immunophenotypic criteria for the diagnosis of non-Hodgkin's lymphoma. Am J Pathol 1987 ; 128 : 181-201.
19. WOOD KM, PALLESEN G, RALFKAIER E, WARNKE R, GATTER KC, MASON DY. Heterogeneity of CD3 antigen expression in T-cell lymphoma. Histopathology 1993 ; 22 : 311-7.
20. HENNI T, GAULARD P, DIVINE M, LE COUEDIC JP, ROCHA D, HAIOUN C et al. Comparison of genetic probe with immunophenotypic analysis in lymphoproliferative disorders. A study of 87 cases. Blood 1988 ; 72 : 1937-43.
21. PICKER LJ, BRENNER MB, WEISS LM, SMITH SD, WARNKE RA. Discordant expression of CD3 and T-cell receptor beta-chain antigens in T-lineage lymphomas. Am J Pathol 1987 ; 129 : 434-40.
22. GAULARD P, BOURQUELOT P, KANAVAROS P, HAIOUN C, LE COUEDIC JP, DIVINE M et al. Expression of the alpha/beta and gamma/delta T-cell receptors in 57 cases of peripheral T-cell lymphomas. Identification of a subset of γδ T-cell lymphomas. Am J Pathol 1990 ; 137 : 617-28.
23. O'CONNOR NTJ, WAINSCOAT JS, WEATHERALL DJ, GATTER KC, FELLER AC, ISAACSON P et al. Rearrangement of the T-cell receptor beta chain gene in the diagnosis of lymphoproliferative disorders. Lancet 1985 ; 1 : 1295-7.
24. BERTNESS V, KIRSCHI I, HOUIS G, JOHNSON B, BUNN PA. T-cell receptor gene rearrangements as clinical markers of human T cell lymphomas. N Engl J Med 1985 ; 573 : 534-40.
25. KANAVAROS P, FARCET JP, GAULARD P, HAIOUN C, DIVINE M, LE COUEDIC JP et al. Recombinative events of the T cell antigsen receptor delta gene in peripheral T cell lymphomas. J Clin Invest 1991 ; 87 : 666-72.
26. GRIESSER H, FELLER A, LENNERT K, TWEEDALE M, MESSNER HA, ZALCBERG J et al. The structure of the T-cell gamma chain gene in lymphoproliferative disorders and lymphoma cell lines. Blood 1986 ; 65 : 592-4.
27. THEODOROU I, BIGORGNE C, DELFAU MH, LAHET C, COCHET G, VIDAUD M et al. VJ rearrangements of the TCR gamma locus in peripheral T-cell lymphomas: analysis by polymerase chain reaction and denaturating gradient gel electrophoresis. J Pathol 1996 ; 178 : 303-10.
28. COATES PJ, D'ARDENNE AJ, KHAN G, KANGRO HO, SLAVIN G. Simplified procedures for applying the polymerase chain reaction to routinely fixed paraffin-wax sections. J Clin Pathol 1991 ; 44 : 115-8
29. WEISS LM, STRICKLER JG, DORFMANN RF, HORNING SJ, WARNKE RA, SKLAR J. Clonal T-cell populations in angioimmunoblastic lymphadenopathy and angioimmunoblastic lymphadenopathy-like lymphonia. Am J Pathol 1986 ; 122 : 392-401.
30. LIPFORD EH, MARGOLICK JB, LONGO DL, FAUCI A, JAFFÉ E. Angiocentric immunoproliferative lesions: a clinicopathologic spectrum of post-thymic T-cell proliferations. Blood 1998 ; 72 : 1674-80.
31. RALFKIAER E, DELSOL G, O'CONNOR NTJ, BRANDTZAEG P, BROUSSET P, VEJLSGAARD GL et al. Malignant lymphomas of true histiocytic origin. A clinical, histological, immunophenotypic and genotypic study. J Pathol 1990 ; 160 : 9-17.
32. WEISS LM, WOOD GS, TRELA M, WARNKE RA, SKLAR J. Clonal T-cell populations in lymphomatoid papulosis: evidence of a lymphoproliferative origin for a clinically benign disease. N Engl J Med 1986 ; 315 : 475-9.
33. WEISS LM, PICKER LJ, GROGAN TM, GROGAN T, WARNKE R, SKLAR J. Absence of clonal beta and gamma T-cell receptor gene rearrangements in a subset of peripheral T-cell lymphomas. Am J Pathol 1988 ; 130 : 436-44.
34. EMILE JF, BOULLAND ML, HAIOUN C, KANAVAROS P, PETRELLA T, DELFAU-LARUE MH et al. CD5- CD56+ TCR silent peripheral T-cell lymphomas are natural killer cell lymphomas. Blood 1996 ; 87 : 1466-73.
35. SCHLEGELBERGER B, HIMMLER A, GODDE E, GROTE W, FELLER AC, LENNERT K. Cytogenetic findings in peripheral T-cell lymphomas as a basis for distinguishing low-grade and high grade lymphomas. Blood 1994 ; 83 : 505-11.
36. VIRGILIO L, NARDUCCI MG, ISOBE M, BILLIPS LG, COOPER MD, CROCE CM et al. Identification of the TCL1 gene involved in T-cell malignancies. Proc Natl Acad Sci USA 1994 ; 91 : 12530-4.
37. WANG CC, TIEN HF, LIN MT, SU IJ, WANG CH, CHUANG SM et al. Consistent presence of isochromosome 7q in hepatosplenic T gamma/delta lymphoma: a new cytogenetic-clinicopathologic entity. Genes Chromosomes Cancer 1995 ; 12 : 161-4.
38. BENNETT JM, CATOVSKY D, DANIEL MT, FLANDRIN G, GALTON DAG, GRALNICK HR et al. Proposals for the classification of chronic (mature) B and T lymphoid leukaemias. J Clin Pathol 1989 ; 42 : 567-84.
39. MATUTES E, BRITO-BABAPULLE V, SWANSBURY V, ELLIS J, MORILLA R, DEARDEN C et al. Clinical and laboratory features of 78 cases of T-prolymphocytic leukemia. Blood 1991 ; 78 : 3269-74.
40. CHAN JKC, SIN VC, WONG KF, NG CS, TSANG WYW, CHAN CH et al. Nonnasal lymphoma expressing the natural killer cell marker CD56: a clinicopathologic study of 49 cases of an uncommon aggressive neoplasm. Blood 1997 ; 89 : 4501-13.
41. BAZARBACHI A, RAPHAEL M, GISSELBRECHT C, HERMINE O. Lymphomes HTLV-1. Aspects anatomo-pathologiques, cliniques et thérapeutiques. In: SOLAL-CÉLIGNY P, BROUSSE N, REYES F, FERMÉ C, COIFFIER B, GISSELBRECHT C eds. Lymphomes. Frison-Roche, Paris, 1997.
42. FRIZZERA AG, MORAN EM, RAPPAPORT H. Angio-immunoblastic lymphadenopathy with dysproteinemia. Lancet 1974 ; 1 : 1070-3.
43. LUKES RJ, TINDLE BH. Immunoblastic lymphadenopathy. A hyper immune entity resembling Hodgkin's disease. N Engl J Med 1975 ; 292 : 1-8.
44. PATSOURIS E, NOEL H, LENNERT K. Angioimmunoblastic lymphadenopathy-type of T-cell lymphoma with a high content of epithelioid cells. Am J Surg Pathol 1989 ; 13 : 262-75.
45. WATANABE S, SATO Y, SHIMOYAMA M, MINATO K, SHIMOSATO Y. Immunoblastic lymphadenopathy and IBL-like T-cell lymphoma. A spectrum of T-cell neoplasia. Cancer 1986 ; 58 : 2224-33.
46. LIPFORD E, SMITH H, PITTALUGA S, JAFFE ES, STEINBERG AD, COSSMAN J. Clonality of angioimmunoblastic lymphadenopathy and implications for its evolution to malignant lymphoma. J Clin Invest 1987 ; 79 : 637-42.
47. PATSOURIS E, NOEL H, LENNERT K. Histological and immunohistological findings in lymphoepithelioid cell lymphoma (Lennert's lymphoma). Am J Surg Pathol 1988 ; 12 : 341-50.
48. FELLER AC, GRIESSER GH, MAK TM, LENNERT K. Lymphoepithelioid lymphoma (Lennert's lymphoma) is a monoclonal proliferation of helper inducer T cells. Blood 1986 ; 68 : 663-7.
49. SPIER CM, LIPPMAN SM, MILLER TP, GROGAN TM. Lennert's lymphoma. A clinicopathologic study with emphasis on phenotype and its relationship to survival. Cancer 1988 ; 61 : 517-25.
50. WALDRON JA, LEECH JH, GLICK AD, FLEXNER JM, COLLINS RD. Malignant lymphoma of peripheral T-lymphocyte origin: immunologic, pathologic and clinical features in six patients. Cancer 1977 ; 40 : 1604-17.
51. STEIN H, MASON DY, GERDES J, O'CONNOR N, WAINSCOAT J, PALLESEN G et al. The expression of the Hodgkin's disease-associated antigen Ki-1 in reactive and neoplastic lymphoid tissue: evidence that Reed-Sternberg cells and histiocytic malignancies are derived from activated lymphoid cells. Blood 1985 ; 66 : 848-58.
52. DELSOL G, AL SAATI T, GATTER KC, GERDES J, SCHWARTING R, CAVERIVIERE P et al. Coexpression of Epithelial Membrane Antigen (EMA), Ki-1 and Interleukin-2 receptor by anaplastic large cell lymphomas. Diagnostic value in so-called malignant histiocytosis. Am J Pathol 1988 ; 130 : 59-70.
53. AGNARSSON BA, KADIN ME. Ki-1 positive large cell lymphoma. A morphologic and immunologic study of 19 cases. Am J Surg Pathol 1988 ; 12 : 264-74.
54. CHAN JKC, NG CS, HUI PK, LEUNG TW, LO ESF, LAU WH et al. Anaplastic large cell Ki-1 lymphoma. Delineation of 2 morphological types. Histopathology 1989 ; 15 : 11-34.
55. PILERI S, FALINI B, DELSOL G, STEIN H, BAGLIONI P, POGGI S et al. Lymphohistiocytic T-cell lymphoma (anaplastic large cell lymphoma CD30+/Ki-1+ with a high content of reactive histiocytes). Histopathology 1990 ; 16 : 383-91.
56. BENHARROCH D, MEGUERIAN-BEDOYAN Z, LAMANT L, AMIN C, BRUGIÉRES L, TERRIER-LACOMBE MJ et al. ALK-positive lymphoma: a single disease with a broad spectrum of morphology. Blood 1998 ; 91 : 2076-84.
57. FOSS HD, ANAGNOSTOPOULOS I, ARAUJO I, ASSAF C, DEMEL G, KUMMER JA et al. Anaplastic large-cell lymphomas of T-cell and null-cell phenotype express cytotoxic molecules. Blood 1996 ; 88 : 4005-11
58. KRENACS L, WELLMANN A, HIMMELMANN AW, BADGI E, JAFFE ES, RAFFELD M. Cytotoxic cell antigen expression in anaplastic large cell lymphomas of T- and null-cell types and Hodgkin's disease: evidence for distinct cellular origin. Blood 1997 ; 89 : 980-9.
59. BOULLAND M-L, KANAVAROS P, WECHSLER J, CASIRAGHI O, GAULARD P. Cytotoxic protein expression in natural killer cell lymphomas and in αβ and 78 peripheral T-cell lymphomas. J Pathol 1997 ; 183 : 432-9.
60. a) are associated with a chromosomal translocation involving 5q35. Br J Haematol 1990 ; 74 : 161-7.
61. MORRIS SW, KIRSTEIN MN, VALENTINE MB, DITTMER KG, SHAPIRO DN, SALTMAN DL et al. Fusion of a kinase gene. ALK, to a nucleolar protein gene. NPM, in non-Hodgkin's lymphoma. Science 1994 ; 263 : 1281-4.
62. BULLRICH F, MORRIS SW, HUMMEL M, PILERI S, STEIN H, CROCE CM. Nucleophosmin (NPM) gene rearrangements in Ki-1 positive lymphomas. Cancer Res 1994 ; 54 : 2873-7.
63. KUEFER MU, LOOK AT, PULFORD K, BEHM FG, PATTENGALE PK, MASON DY et al. Retrovirus-mediated gene transfer of NPM-ALK causes lymphoid malignancy in mice. Blood 1997 ; 90 : 2901-10.
64. LAMANT L, MEGGETTO F, AL SAATI T, BRUGIÈRES L, BRESSAC DE PAILLERETS B, DASTUGUE N et al. High incidence of the t(2;5) (p23,q35) translocation in anaplastic large cell lymphoma and its lack of detection in Hodgkin's disease. Comparison of cytogenetics analysis, reverse transcriptase-polymerase chain reaction and p80 staining. Blood 1996 ; 87 : 284-91.
65. YEE HT, PONZONI M, MERSON A, GOLDSTEIN M, SCARPA A, CHILOSI M et al. Molecular characterization of the t(2;5) (p23;q35) translocation in anaplastic large cell lymphoma (Ki 1) and Hodgkin's disease. Blood 1996 ; 87 : 1081-8.
66. SHIOTA M, FUJIMOTO J, TAKENAGA M, SATO H, ICHINOHASAMA R, ABE M et al. Diagnosis of t(2;5) (p23;q35)- associated Ki-1 lymphoma with immunohistochemistry. Blood 1994 ; 84 : 3648-52.
67. BELJAARDS RC, KAUDEWITZ P, BERTI E, GIANOTTI R, NEUMANN C, Rosso R et al. Primary cutaneous CD30-positive large cell lymphoma: definition of a new type of cutaneous lymphoma with a favorable prognosis. A European Multicenter Study on 47 patients. Cancer 1993 ; 71 : 2097-104.
68. TILLY H, GAULARD P, LEPAGE E, DUMONTET C, DIEBOLD J, PLANTIER I et al. Primary anaplastic large-cell lymphoma in adults: clinical presentation, immunophenotype and outcome. Blood 1997 ; 90 : 3727-34.
69. ISAACSON PG, NORTON AJ eds. In Extranodal lymphomas. London, Churchill Livingstone, 1995.
70. MURRAY A, CUEVAS EC, JONES DB, WRIGHT DH. A study of the immunohistochemistry and T-cell clonality of enteropathy-associated T-cell lymphoma. Am J Pathol 1995 ; 146 : 509-19.
71. SCHMITT-GRAFF A, HUMMEL M, ZEMLIN M, SCHNEIDER T, ULLRICH R, HEISE W et al. Intestinal T-cell lymphoma: a reassessment of cytomorphological and phenotypic features in relation to patterns of small bowel remodelling. Virchows Arch 1996 ; 429 : 27-36.
72. ASHTON-KEY M, DISS T, PAN L, Du M, ISAACSON PG. Molecular analysis of T-cell clonality in ulcerative jejunitis and enteropathy-associated T-cell lymphomas. Am J Pathol 1997 ; 151 : 493-8.
73. KANAVAROS P, LESCS MC, BRIÈRE J, DIVINE M GALATEAU F, JOAB I et al. Nasal T-cell lymphoma: a clinicopathologic entity associated with peculiar phenotype and with Epstein-Barr virus. Blood 1993 ; 81 : 2688-95.
74. LIANG R, TODD D, CHAN TK, CHIU E, LIE A, KWONG YL et al. Treatment outcome and prognostic factors for primary nasal lymphoma. J Clin Oncol 1995 ; 13 : 666-70.
75. HARABUCHI Y, YAMANAKA N, KATAURA A, IMAI S, KINOSHITA T, MIZUNO F et al. Epstein-Barr virus in nasal T-cell lymphomas in patients with lethal midline granuloma. Lancet 1990 ; 335 : 128-30.
76. WONG KF, CHAN JKC, NG CS, LEE KC, TSANG WYW, CHEUNG MMC. CD56 (NKH1)-positive hematolymphoid malignancies: an aggressive neoplasm featuring frequent cutaneous/mucosal involvement, cytoplasmic azurophilic granules, and angiocentricity. Hum Pathol 1992 ; 23 : 798-804.
77. SUZUMIYA J, TAKESHITA M, KIMURA M, KIKUCHI M, UCHIDA T, HISANO S et al. Expression of adult and fetal natural killer cell markers in sinonasal lymphomas. Blood 1994 ; 83 : 2255-60.
78. KANAVAROS P, BRIÉRE J, LESCS MC, GAULARD P. EBV in non-Hodgkin's lymphomas of the upper respiratory tract: association with sinonasal localisation and expression of NK and/or T-cell antigens by tumour cells. J Pathol 1996 ; 178 : 303-10.
79. KERN WF, SPIER CM, HANNEMAN EH, MILLER TP, MATZNER M, GROGAN TM. Neural cell adhesion molecule-positive peripheral T-cell lymphoma: a rare variant with a propensity for unusual sites of involvement. Blood 1992 ; 79 : 2432-7.
80. KUMAR S, KRENACS L, MEDEIROS J, ELENITOBA-JOHNSON KSJ, GREINER TC, SORBARA L et al. Subcutaneous panniculitic T-cell lymphoma is a tumor of cytotoxic T lymphocytes. Hum Pathol 1998 ; 29 : 397-403.
81. GAULARD P, ZAFRANI ES, MAVIER P, ROCHA FD, FARCET JP, DIVINE M et al. Peripheral T-cell lymphoma presenting as predominant liver disease. A report of 3 cases. Hepatology 1986 ; 6 : 864-8.
82. FARCET JP, GAULARD P, MAROLLEAU JP, LE COUEDIC JP, HENNI T, GOURDIN M et al. Hepatosplenic T-cell lymphoma: sinusal/sinusoidal localization of malignant cells expressing the T-cell receptor 76. Blood 1990 ; 75 : 2213-9.
83. MASTOVICH S, RATECH H, WARE RE, MOORE JO, BOROWITZ MJ. Hepatosplenic T-cell lymphoma: an unusual case of a 78 T-cell lymphoma with blast like terminal transformation. Hum Pathol 1994 ; 25 : 102-8.
84. COOK CB, KRENACS L, STETLER-STEVENSON M, GREINER TC, RAFFELD M, KINGMA DW et al. Hepatosplenic T-cell lymphoma: a distinct clinicopaihologic entity of cytotoxic gamma/ delta T-cell origin. Blood 1996 ; 88 : 4265-74
85. Ross CW, SCHNITZER B, SHELDON S, BRAUN DK, HANSON CA. Gamma/delta T-cell post transplantation lymphoproliferative disorder primarily in the spleen. Am J Clin Pathol 1994 ; 102 : 310-5.
86. ARNULF B, COPIE-BERGMAN C, DELFAU-LARUE MH, LAVERGNE-SLOVE A, BOSQ J, WECHSLER J et al. Non-hepatosplenic γδ T-cell lymphoma: a subset of cytotoxic lymphomas with mucosal or skin localization. Blood 1998 ; 91 : 1723-31.
87. SABOURIN JC, KANAVAROS P, BRIÈRE J, LESCS MC, PETRELLA T, ZAFRANI ES et al. Epstein-Barr virus (EBV) genomes and EBV-encoded latent membrane protein (LMP) in pulmonary lymphomas occurring in non immunocompromised patients. Am J Surg Pathol 1993 ; 17 : 995-1002.
88. GUINEE D JR, JAFFE E, KINGMA D, FISHBACK N, WALLBERG K, KRISHNAN J et al. Pulmonary lymphomatoid granulomatosis. Evidence for a proliferation of Epstein Barr virus infected B-lymphocytes with a predominant T-cell component and vasculitis. Am J Surg Pathol 1995 ; 18 : 753-64.
89. NICHOLSON AG, WOTHERSPOON AC, Drss TC, SINGH N, BUTCHER DN, PAN LX et al. Lymphomatoid granulomatosis: evidence that some cases represent Epstein-Barr virus-associated B-cell lymphoma. Histopathology 1996 ; 29 : 317-24.
90. D'AMORE F, JOHANSEN P, HOURMAND A, WEISENBURGER DD, MORTENSEN LS. Epstein-Barr virus genome in non-Hodgkin's lymphomas occurring in immunocompetent patients: highest prevalence in non lymphoblastic T-cell lymphoma and correlation with a poor prognosis. Danish Lymphoma Study Group, LYFO. Blood 1996 ; 87 : 1045-55.
91. HAMILTON-DUTOIT SJ, PALLESEN G. A survey of Epstein-Barr virus (EBV) gene expression in sporadic non-Hodgkin's lymphomas: detection of EBV in a subset of peripheral T-cell lymphomas. Am J Pathol 1992 ; 140 : 1315-25.
92. KORBJUHN P, ANAGNOSTOPOULOS I, HUMMEL M, TIEMANN M, DALLENBACH F, PARWARESCH MR et al. Frequent latent Epstein-Barr virus infection of neoplastic T cells and bystander B cells in human immunodeficiency virus-negative european peripheral pleomorphic T-cell lymphomas. Blood 1993 ; 82 : 217-23.
93. DE BRUIN PC, JIWA NM, VAN DER VALK P, VAN HEERDE P, GORDIJN R, OSSENKOPPELE GJ et al. Detection of Epstein Barr virus nucleic acid sequences and protein in nodal T-cell lym phomas: relation between latent membrane protein-1 positivity and clinical course. Histopathology 1993 ; 23 : 509-18.
94. HSU SM, WALDRON JW, HSU PL, HOUGH AJ. Cytokines in malignant lymphomas. Hum Pathol 1993 ; 24 : 1040-57.
95. MERZ H, HOUSSIAU FA, ORSCHESCHEK K, RENAULD JC, FLIEDNER A, HERIN M et al. Interleukin-9 expression in human malignant lymphomas: Unique association with Hodgkin's disease and large cell anaplastic lymphoma. Blood 1991 ; 78 : 1311-7.
96. FOSS HD, ANAGNOSTOPOULOS I, HERBST H, GREBE M, ZIEMANN K, HUMMEL M et al. Patterns of cytokine gene expression in peripheral T-cell lymphoma of angioimmunoblastic lymphadenopathy type. Blood 1995 ; 85 : 2862-9.
97. HSU SM, WALDRON JA, FINK L, KING C, XIE SS, MANSOURI A et al. Pathogenetic significance of interleukin-6 in angioimmunoblastic lymphadenopathy T-cell lymphoma. Hum Pathol 1993 ; 24 : 126-31.
98. DURKOP H, LATZA U, HUMMEL M, EITELBACH F, SEED B, STEIN H. Molecular cloning and expression of a new member of the nerve growth factor receptor family that is characteristic of Hodgkin's disease. Cell 1992 ; 68 : 421-30.
99. SMITH CA, GRUSS HJ, DAVIS T, ANDERSON D, FARRAH T, BAKER E et al. CD30 antigen, a marker for Hodgkin's lymphoma, is a receptor whose ligand defines an emerging family of cytokines with homology to TNF. Cell 1993 ; 73 : 1349-60.
100. GRUSS HJ, BOIANI N, WILLIAMS DE, ARMITAGE RJ, SMITH CA, GOODWIN RG. Pleiotropic effects of the CD30 ligand on CD30-expressing cells and lymphoma cell lines. Blood 1994 ; 83 : 2045-56.
101. PICKER LJ, BUTCHER EC. Physiological and molecular mechanisms of lymphocyte homing. Annu Rev Immunol 1992 ; 10 : 561-91.
102. GEISSMAN F, PATEY-MARIAUD DE SERRE N, BROUSSE N. Molécules d'adhérence en hématopathologie. Ann Pathol 1998 ; 18 : 253-60.